A nurse is providing patient education to a client who has been prescribed bethanechol chloride (Urecholine). The nurse will include that bethanechol chloride (Urecholine) is ordered to treat which of the following?

Choice A rationale Bethanechol chloride is a direct-acting muscarinic cholinergic agonist, which stimulates the parasympathetic nervous system. This stimulation increases bladder tone and contractility of the detrusor muscle, and it also relaxes the trigone and sphincter, actions which promote micturition, making it contraindicated for treating urinary incontinence. Choice B rationale Urinary tract infections (UTIs) are primarily treated with antibiotics to eradicate the bacterial pathogen causing the infection, not with cholinergic agonists. Bethanechol's action of promoting urination does not directly treat the underlying microbial cause of a UTI, thus it is not the primary indication for this medication. Choice C rationale Reflex incontinence is typically associated with a neurological impairment causing involuntary bladder contractions. While bethanechol increases detrusor muscle tone, the primary treatments often involve antispasmodics, anticholinergics, or scheduled voiding, not agents that increase the contraction reflex. Choice D rationale Bethanechol chloride is prescribed to treat non-obstructive urinary retention, especially post-operative or postpartum retention. By acting as a cholinergic agent, it enhances the parasympathetic nerve effects on the bladder, leading to detrusor muscle contraction and subsequent bladder emptying.